Tag
AI decision support significantly improves primary care clinicians’ accuracy in spirometry diagnosis, especially for COPD, addressing a key gap in respiratory disease management.
AI offers transformative potential for clinical trials, but realizing its value demands a robust, stakeholder-driven framework to guide adoption and assess impact across the trial lifecycle.
Limited demographic data transparency in FDA-authorized AI devices for Alzheimer’s may hinder equitable care and generalizability, highlighting a crucial need for improved dataset representativeness and regulatory oversight.
